Company Profiles

driven by the PitchBook Platform

Acetylon Pharmaceuticals

Description

Developer of small-molecule drugs. The company is developing next-generation selective small molecule histone deacetylase (HDAC) inhibitors, which allow for epigenetic regulation of gene and protein function for the treatment of patients with critical unmet medical needs.

2008

Founded

M&A

Status

11-50

Employees

M&A

Latest Deal Type

$200M

Latest Deal Amount

$153M

Total Amount Raised

Description

Developer of small-molecule drugs. The company is developing next-generation selective small molecule histone deacetylase (HDAC) inhibitors, which allow for epigenetic regulation of gene and protein function for the treatment of patients with critical unmet medical needs.

Website:

www.acetylon.com

Ownership Status

Acquired/Merged

Financing Status

Formerly VC-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Seaport Center, 70 Fargo Street Suite 205 Boston, MA 02210United States +1 (617) 245-1300
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Acetylon Pharmaceuticals's full profile, request a free trial.

    Acetylon Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Acetylon Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Acetylon Pharmaceuticals Executive Team (16)

    NameTitleBoard
    Seat
    Contact
    Info
    Min YangDirector, Biomarker Development
    Faye SeyediDirector, Drug Substance Manufacturing
    Ken JacobsDirector, Program Management
    Kailash Bhol Ph.DSenior Director, Preclinical Development
    Denise HayesSenior Director, Regulatory Affairs
    Min Yang Director, Biomarker Development
    Faye Seyedi Director, Drug Substance Manufacturing
    Ken Jacobs Director, Program Management
    Kailash Bhol Ph.D Senior Director, Preclinical Development
    Denise Hayes Senior Director, Regulatory Affairs

    Acetylon Pharmaceuticals Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Bruce Downey JDSelfBoard Member000 0000
    Elena Prokupets Ph.DSelfBoard Member000 0000
    James Bradner MDAcetylon PharmaceuticalsScientific Founder & Board Member000 0000
    Kenneth Anderson MDAcetylon PharmaceuticalsScientific Founder & Board Member000 0000
    Marc CohenAcetylon PharmaceuticalsCo-Founder & Chairman000 0000
    Bruce Downey JD Board Member Self
    Elena Prokupets Ph.D Board Member Self
    James Bradner MD Scientific Founder & Board Member Acetylon Pharmaceuticals
    Kenneth Anderson MD Scientific Founder & Board Member Acetylon Pharmaceuticals
    Marc Cohen Co-Founder & Chairman Acetylon Pharmaceuticals
    Request full access to PitchBook